Pharmaceutical Technology's In the Lab eNewsletter, April 2022

The challenges of conducting protein characterization can be overcome through the use of technologies that empower scientists in their analytical work.

Standardization is needed in CAR-T cell therapy development due to its inherent complexity.

Research from the University of Michigan showed that Terahertz light can be used to probe both the structures of molecular crystals and their twists.

Thermo Fisher Scientific’s new Gibco CTS Xenon Electroporation System aims to provide easier scale up for cell therapies, from clinical development to commercial manufacturing.

Under the two-year task order, ATCC will continue to support the DCEG MEAS program in receiving, processing, storing, analyzing, and distributing clinical specimens from different cancer types.

Spectrum Chemical is adding twelve products to its bioCERTIFIED product line.

ProteoGenix’s new XtenCHO Transient Expression can achieve up to ten times higher yields than market-leading CHO systems.

The US Congress approved a federal spending package that increases funding for a range of programs to advance health and medicine.

Flow Eighteeen38 is receiving a €5 million (US$5.58 million) investment from its parent company, FairJourney Biologics.